Akari Therapeutics Plc (AKTX)
8.72
-0.12
(-1.36%)
USD |
NASDAQ |
Oct 02, 16:00
8.65
-0.07
(-0.80%)
After-Hours: 20:00
Akari Therapeutics EPS Diluted (Quarterly) : -2.404 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.404 |
| March 31, 2026 | -9.584 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -7.789 |
| June 30, 2025 | -2.438 |
| March 31, 2025 | -0.1357 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | -0.2374 |
| June 30, 2024 | -0.8025 |
| March 31, 2024 | 0.00 |
| March 31, 2023 | 0.00 |
| June 30, 2022 | -1.92 |
| March 31, 2022 | -1.94 |
| December 31, 2021 | -2.44 |
| September 30, 2021 | -0.62 |
| June 30, 2021 | -2.26 |
| March 31, 2021 | -3.04 |
| December 31, 2020 | -3.54 |
| September 30, 2020 | 21.99 |
| June 30, 2020 | -198.89 |
| March 31, 2020 | -119.28 |
| December 31, 2019 | -7.30 |
| Date | Value |
|---|---|
| September 30, 2019 | -2.60 |
| June 30, 2019 | -5.12 |
| March 31, 2019 | -3.22 |
| December 31, 2018 | -4.44 |
| September 30, 2018 | -4.70 |
| June 30, 2018 | -20.00 |
| March 31, 2018 | -1.76 |
| December 31, 2017 | -20.00 |
| September 30, 2017 | -20.00 |
| June 30, 2017 | -0.5435 |
| March 31, 2017 | -20.00 |
| December 31, 2016 | -18.32 |
| September 30, 2016 | -0.72 |
| June 30, 2016 | -10.96 |
| March 31, 2016 | -5.693 |
| December 31, 2015 | 19.85 |
| September 30, 2015 | -120.27 |
| June 30, 2015 | -58.33 |
| March 31, 2015 | -75.04 |
| December 31, 2013 | -61.83 |
| September 30, 2013 | 59.41 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -0.5804 |
| Cellectis SA | -0.2165 |
| Bicycle Therapeutics Plc | -0.7224 |
| Autolus Therapeutics Plc | -0.1472 |
| Evaxion AS | -0.4464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.816M |
| Total Expenses (Quarterly) | 4.816M |
| Enterprise Value | 8.202M |
| Earnings Yield | -226.8% |